← brief for 2026-09-09 · Slowing decline

Association of GLP-1 Receptor Agonists Versus Other Antidiabetic Medications With Cardiovascular, Renal, and Liver Outcomes in Patients With Type 2 Diabetes.

Article C Peer reviewed Observational

Key takeaways

Researchers compared GLP-1 drugs, the same family as semaglutide, against seven other diabetes medicines in Chinese adults with type 2 diabetes. They used regional health records from 2018 to 2024 and followed heart, kidney, and liver outcomes. This is a records study, so it can show a link but cannot prove the drug caused the difference. People given one drug often differ from people given another in ways the records do not capture.

Who did this work

Fan Y · Peng N · Jiang L · Wei R · Lu G · Zhang S · Mu C · Xue M · Lyu B · Yao D

Source

Article · PubMed, the drug frontier · 2026 Sep 8
https://pubmed.ncbi.nlm.nih.gov/42712110/